Manage your inflammation and set a positive tone for your day with these simple morning habits.

If your skin feels more sensitive, slower to recover, or harder to manage, the cause may go beyond your routine — starting ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled ...

It’s the body’s normal response to infection or injury — but chronic inflammation can lead to health issues. Here’s where inflammation can go wrong and tips for preventing it.

RIPK1 inhibition reduced inflammation and keratinocyte cell death in lichen planus and CLE models. Could this be a new treatment approach? Read more.

A potential breakthrough in the treatment of type 1 mediated chronic inflammatory skin diseases (ISD) has emerged, as researchers have identified receptor-interacting serine/threonine-protein kinase 1 ...

Reynold A. Panettieri Jr., MD, explores the impact of COPD and asthma on patients' quality of life, highlighting exercise limitations and sleep disturbances. Jonathan Silverberg, MD, PhD, MPH, ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting about 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting ...

From babyhood to adulthood, the bacteria and fungi on your skin help train your immune system—but when that balance tips, chronic inflammation can follow. This new review reveals how and why. Study: ...

It’s well past time for our community to take the phrase, “you are what you eat,” more seriously. There is so much about our ...

Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms ...